Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.70
Bid: 406.40
Ask: 406.60
Change: 6.70 (1.67%)
Spread: 0.20 (0.049%)
Open: 408.90
High: 409.60
Low: 404.30
Prev. Close: 401.00
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

19 Oct 2016 07:00

RNS Number : 8825M
Rentokil Initial PLC
19 October 2016
 

RENTOKIL INITIAL PLC (RTO)

THIRD QUARTER TRADING UPDATE

19 October 2016

 

 

 (£m)

Q3 2016

Growth

AER

AER

CER

Revenue

578.3

32.1%

15.7%

Revenue - ongoing operations1

576.7

33.1%

16.6%

 

 

Performance Overview (CER)

Revenue from ongoing operations increased by 16.6% in Q3, of which 3.1% was organic (H1 2016: 2.5%) and 13.5% was from acquisitions. Year to date we have delivered organic growth of 2.7%. Pest Control delivered an excellent performance in the quarter, growing organically by 5.9%, and our Hygiene business demonstrated further improvement, growing organically by 3.2%. Growth in our Emerging (+20.4%) and Growth (+26.3%) markets was once again particularly strong. Our operations within the Manage for Value quadrant grew by 2.3% while the rate of revenue decline in our Protect and Enhance markets was largely unchanged from Q1 and Q2 at 1%.

The majority of our regions have performed well in the period reflecting good performances in Asia, Pacific, Latin America, the UK and in our largest market, North America. While conditions remain tough in parts of Europe, particularly in France, overall the region delivered modest revenue growth in Q3.

Also in the quarter Rentokil was proud to provide in partnership with the Rio de Janeiro health authorities, Pest Control, including innovative mosquito elimination, in advance of and during the very successful Rio 2016 Olympic and Paralympic Games.

M&AThe Company acquired 13 businesses in the quarter including ten in Pest Control and two in Hygiene, as well as the acquisition of Residex, a Pest Control and Turf Products Distribution business, as announced on 7 July. All of the acquisitions were in Emerging or Growth markets. Combined annual revenues of the businesses acquired totalled £88m in the 12 months immediately prior to acquisition. For the nine months to 30 September we have acquired 33 businesses with combined annual revenues of £109m. The integrations of Steritech and Residex are both progressing well.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with our performance in the third quarter. Pest Control grew organically by almost 6%, reflecting good performances in Asia, Pacific, Latin America, the UK and our key growth market of North America. I am also encouraged by ongoing traction in our Hygiene business which delivered organic growth of 3.2%. Our guidance for the full year is unchanged."

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

John Sunnucks

Bell Pottinger

0203 772 2549

 

 

 

AER - actual exchange rates; CER - constant 2015 exchange rates

 

1ongoing revenue excludes the financial performance of disposed and closed businesses but includes results from acquisitions

 

This announcement contains statements that are, or may be, forward-looking regarding the group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTFMMMGVRFGVZM
Date   Source Headline
29th Sep 20167:00 amRNSAdditional Listing
26th Sep 20164:48 pmRNSDirector/PDMR Shareholding
22nd Aug 20164:56 pmRNSHolding(s) in Company
28th Jul 20167:00 amRNSHalf Yearly Report
27th Jul 20167:00 amRNSCollaboration with Google and PA Consulting Group
7th Jul 20167:00 amRNSAcquisition, CDC Contract Win and Trading Update
29th Jun 20167:00 amRNSDirectorate Change
29th Jun 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20165:27 pmRNSHolding(s) in Company
17th May 20165:06 pmRNSDirector/PDMR Shareholding - Replacement
13th May 20165:04 pmRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSResult of AGM
11th May 20163:59 pmRNSTotal Voting Rights
20th Apr 20167:00 amRNS1st Quarter Results
8th Apr 20164:35 pmRNSAnnual Financial Report - Replacement
8th Apr 20164:08 pmRNSAnnual Financial Report
14th Mar 20167:05 amRNSDirector/PDMR Shareholding
26th Feb 201611:38 amRNSHolding(s) in Company
25th Feb 20167:00 amRNSFinal Results
24th Feb 20164:55 pmRNSHolding(s) in Company
23rd Feb 20161:39 pmRNSHolding(s) in Company
1st Feb 20164:12 pmRNSHolding(s) in Company
28th Jan 20165:26 pmRNSHolding(s) in Company
27th Jan 20164:49 pmRNSHolding(s) in Company
21st Jan 20164:22 pmRNSHolding(s) in Company
15th Jan 201612:33 pmRNSHolding(s) in Company
12th Jan 20166:05 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSRentokil Initial Q4 2015 Acquisitions
25th Nov 20155:17 pmRNSHolding(s) in Company
23rd Nov 20157:00 amRNSHolding(s) in Company
10th Nov 20155:26 pmRNSHolding(s) in Company
6th Nov 201510:46 amRNSChange to Director's details
5th Nov 20157:00 amRNSQ3 Trading Update
20th Oct 20155:08 pmRNSHolding(s) in Company
15th Oct 20159:50 amRNSChange to Director's details
2nd Oct 20157:00 amRNSAcquisition
2nd Sep 20155:19 pmRNSHolding(s) in Company
2nd Sep 20157:00 amRNSHolding(s) in Company
1st Sep 20157:03 amRNSAcquisition
28th Aug 20157:07 amRNSAcquisition
30th Jul 20157:00 amRNSHalf Yearly Report
2nd Jul 20152:00 pmRNSHolding(s) in Company
24th Jun 20153:56 pmRNSDirector/PDMR Shareholding
15th Jun 20155:42 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSDirector/PDMR Shareholding
14th May 20158:12 amRNSResult of AGM
8th May 201510:39 amRNSDirector/PDMR Shareholding
7th May 20153:53 pmRNSHolding(s) in Company
6th May 20155:17 pmRNSHolding(s) in Company
1st May 20157:00 amRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.